Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
LANCET NEUROLOGY
Rivista
Codice:
E184234
ISSN:
1474-4422
Dati Generali
Dati Generali
Pubblicazioni (73)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Articolo
2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
Articolo
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Articolo
A need for new treatments in narcolepsy.
Articolo
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Articolo
Application of diagnostic criteria for optic neuritis – Authors' reply
Articolo
Assessment of system dysfunction in the brain through MRI-based connectomics
Articolo
Association between pathological and MRI findings in multiple sclerosis
Articolo
Association between pathological and MRI findings in multiple sclerosis
Articolo
COVID-19: can we learn from encephalitis lethargica?
Articolo
Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study
Articolo
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Articolo
Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study
Articolo
Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis
Articolo
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management
Articolo
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial
Articolo
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
Articolo
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
Articolo
Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
Articolo
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes
Articolo
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
Articolo
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Articolo
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Articolo
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
Articolo
EFFICACY OF ROTIGOTINE FOR TREATMENT OF MODERATE-TO-SEVERE RESTLESS LEGS SYNDROME: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Articolo
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation
Articolo
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Articolo
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study
Articolo
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
Articolo
Fluid balance and outcome in critically ill patients with traumatic brain injury (CENTER-TBI and OzENTER-TBI): a prospective, multicentre, comparative effectiveness study
Articolo
How the brain repairs itself: new therapeutic strategies in inflammatory and degenerative CNS disorders
Articolo
Inflammation in multiple sclerosis: the good, the bad, and the complex
Articolo
Insights into migraine attacks from neuroimaging
Articolo
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
Articolo
Iron chelation in early Parkinson's disease
Articolo
KIR 4.1: another misleading expectation in multiple sclerosis?
Articolo
Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study
Articolo
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study
Articolo
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
Articolo
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
Articolo
MRI in multiple sclerosis: current status and future prospects
Articolo
MRI in the diagnosis of MS: expanding the concept of “no better explanation”
Articolo
MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis
Articolo
Moving towards a connectomic view of neuro-oncology
Articolo
Multiple sclerosis diagnosis: a biologically driven perspective
Articolo
Multiple sclerosis: new measures to monitor the disease
Articolo
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes
Articolo
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Articolo
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Articolo
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
Articolo
Prevention Regimen for effectively avoiding second strokes (PRoFESS) study group
Articolo
Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis
Articolo
RADIANCE Study Group. Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomized, placebo-controlled, phase 2 trial.
Articolo
Radiologically isolated syndrome: knowns and unknowns
Articolo
Rethinking multiple sclerosis treatment strategies
Articolo
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
Articolo
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
Articolo
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Articolo
Sclerosi Multipla:trattamento precoce ed adeguato
Articolo
Secondary progressive multiple sclerosis: current knowledge and future challenges
Articolo
Simvastatin and cognition in multiple sclerosis
Articolo
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
Articolo
Spinal-cord MRI in multiple sclerosis.
Articolo
Surgery versus conservative treatment for traumatic acute subdural haematoma: a prospective, multicentre, observational, comparative effectiveness study
Articolo
The hippocampus in multiple sclerosis
Articolo
The multiple sclerosis mystery: is there a vascular component?
Articolo
The use of quantitative magnetic-resonance-based techniques to monitor the evolution of multiple sclerosis
Articolo
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis
Articolo
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Articolo
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
Articolo
daclizumab in active relapsing multiple clerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Articolo
effects of apsirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention regimen for Effectively Avoiding Second Strokes (Profess) trial: a double-bind, active and placebo controled study
Articolo
lomg-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5 year active treatment extension of the phase 2 BENEFIT trial
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
